387 related articles for article (PubMed ID: 7527591)
21. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
22. Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas.
Le QT; Taira A; Budenz S; Jo Dorie M; Goffinet DR; Fee WE; Goode R; Bloch D; Koong A; Martin Brown J; Pinto HA
Cancer; 2006 May; 106(9):1940-9. PubMed ID: 16532436
[TBL] [Abstract][Full Text] [Related]
23. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
24. Combined modalities in the treatment of head and neck cancers.
Aisner J; Hiponia D; Conley B; Jacobs M; Gray W; Belani CP
Semin Oncol; 1995 Jun; 22(3 Suppl 6):28-34. PubMed ID: 7541154
[TBL] [Abstract][Full Text] [Related]
25. [Cisplatin/5-FU versus carboplatin/5-FU. 5 year follow-up].
Ebeling O; Eckel HE; Volling P; Heitmann K; Vössing M
HNO; 1994 Oct; 42(10):629-35. PubMed ID: 8002371
[TBL] [Abstract][Full Text] [Related]
26. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
Koukourakis MI; Giatromanolaki A; Fountzilas G; Sivridis E; Gatter KC; Harris AL
Clin Cancer Res; 2000 Feb; 6(2):381-9. PubMed ID: 10690514
[TBL] [Abstract][Full Text] [Related]
27. [The radiochemotherapy of advanced head-neck tumors--what is certain?].
Wendt TG
Strahlenther Onkol; 1996 Aug; 172(8):409-16. PubMed ID: 8765342
[TBL] [Abstract][Full Text] [Related]
28. Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: a phase II study--preliminary results.
Chougule P; Wanebo H; Akerley W; McRae R; Nigri P; Leone L; Safran H; Ready N; Koness RJ; Radie-Keane K; Cole B
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-57-S19-61. PubMed ID: 9427268
[TBL] [Abstract][Full Text] [Related]
29. Randomized trials of induction chemotherapy. A critical review.
Forastiere AA
Hematol Oncol Clin North Am; 1991 Aug; 5(4):725-36. PubMed ID: 1890063
[TBL] [Abstract][Full Text] [Related]
30. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
[TBL] [Abstract][Full Text] [Related]
31. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
[TBL] [Abstract][Full Text] [Related]
32. [Current status of clinical trials on pre- and postoperative chemotherapy for head and neck cancer].
Inuyama Y; Fukuda S; Horiuchi M
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():338-47. PubMed ID: 7986113
[TBL] [Abstract][Full Text] [Related]
33. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
[TBL] [Abstract][Full Text] [Related]
34. [Treatment for recurrent head and neck carcinomas].
Tsukuda M
Gan To Kagaku Ryoho; 1998 Feb; 25(3):303-8. PubMed ID: 9492820
[TBL] [Abstract][Full Text] [Related]
35. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
[TBL] [Abstract][Full Text] [Related]
36. Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5-FU chemotherapy.
Taylor SG; Murthy AK; Showel JL; Caldarelli DD; Hutchinson JC; Holinger LD; Kramer T; Kiel K
Cancer Treat Rep; 1985 Sep; 69(9):933-9. PubMed ID: 3928158
[TBL] [Abstract][Full Text] [Related]
37. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.
Peters LJ; O'Sullivan B; Giralt J; Fitzgerald TJ; Trotti A; Bernier J; Bourhis J; Yuen K; Fisher R; Rischin D
J Clin Oncol; 2010 Jun; 28(18):2996-3001. PubMed ID: 20479390
[TBL] [Abstract][Full Text] [Related]
38. Induction chemotherapy as initial treatment for advanced head and neck cancer: a model for the multidisciplinary treatment of solid tumors.
Clark JR; Fallon BG; Frei E
Important Adv Oncol; 1987; ():175-95. PubMed ID: 3331380
[TBL] [Abstract][Full Text] [Related]
39. [Chemotherapy of advanced head and neck tumors. A prospective randomized study comparing the effectiveness of chemotherapy alone to a chemo-radiotherapy procedure].
Klima A; von Ilberg C; Klippstein T; Szepesi S
Laryngol Rhinol Otol (Stuttg); 1987 Apr; 66(4):205-10. PubMed ID: 2439861
[TBL] [Abstract][Full Text] [Related]
40. Controversies in the multimodality management of head and neck cancer.
Thomas CR; Taylor SG
Hematol Oncol Clin North Am; 1991 Aug; 5(4):769-81. PubMed ID: 1890066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
